Immediate Impact
64 standout
Citing Papers
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
2024 Standout
Works of Ilan Yanuv being referenced
Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ilan Yanuv | 637 | 200 | 261 | 25 | 718 | |
| Aliza Rozenberg | 637 | 200 | 262 | 26 | 719 | |
| Gary K. Yang | 362 | 149 | 351 | 28 | 618 | |
| Amanda Mather | 492 | 267 | 262 | 22 | 786 | |
| Ryo Kodera | 360 | 169 | 185 | 16 | 632 | |
| Xiaoni Liu | 579 | 314 | 346 | 19 | 764 | |
| Daniel Lorber | 395 | 125 | 158 | 24 | 765 | |
| Herbert Gershberg | 379 | 154 | 108 | 40 | 774 | |
| Fotini Adamidou | 393 | 92 | 202 | 29 | 618 | |
| Joaquim Calado | 446 | 445 | 313 | 30 | 798 | |
| Norm Rosenthal | 616 | 362 | 283 | 19 | 769 |
All Works
Loading papers...